Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynairgen Regulatory News (SNG)

  • There is currently no data for SNG

Total Voting Rights

30 Jun 2009 09:56

RNS Number : 7642U
Synairgen plc
30 June 2009
 



30 June 2009

Synairgen plc

("Synairgen" or "the Company")

Total Voting Rights

 

For the purposes of the Financial Services Authority's disclosure and Transparency Rules, the Company's total issued share capital at the date of this notice is 59,745,249. 

The Company's issued share capital consists of 59,745,249 ordinary shares of 1p each, with one voting right per share. There are no shares held in treasury.

The total number of voting rights in the Company is therefore 59,745,249.

The above figure of 59,745,249 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company, under the Disclosure and Transparency Rules.

For more information please contact:

 

Synairgen plc  Tel: + 44 (0) 2380 512 800

Richard Marsden, Managing Director

John Ward, Finance Director

Matrix Corporate Capital  Tel: + 44 (0) 20 3206 7000

Alastair Stratton

Anu Tayal

Threadneedle Communications  Tel: + 44 (0) 20 7653 9850

Graham Herring

Josh Royston

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TVRCKKKPFBKKAAN
Date   Source Headline
22nd Mar 20167:00 amRNSPositive LOXL2 results
3rd Mar 20167:00 amRNSNotice of Preliminary Results
16th Nov 20154:11 pmRNSAdoption of FRS 101 - Reduced Disclosure Framework
13th Nov 20153:08 pmRNSHolding(s) in Company
13th Nov 201511:41 amRNSHolding(s) in Company
13th Nov 20157:00 amRNSHolding(s) in Company
12th Nov 20157:00 amRNSDirectors' Share Purchase
28th Oct 20157:00 amRNSGrant of options
16th Sep 20157:00 amRNSInterim Results
21st Aug 20157:00 amRNSNotice of Interim Results
5th Aug 20157:00 amRNSSynairgen announces research collaboration
22nd Jul 20157:00 amRNSAstraZeneca commences Phase II Trial
22nd Jun 20151:41 pmRNSResult of AGM
2nd Jun 20159:37 amRNSHolding(s) in Company
15th May 201511:04 amRNSNotice of AGM
22nd Apr 20155:03 pmRNSPosting of Annual Report and Accounts
5th Mar 201512:55 pmRNSRichard Griffiths increases stake to 6.1 percent
3rd Mar 20157:00 amRNSPreliminary Results
12th Feb 201512:44 pmRNSHolding(s) in Company
11th Nov 20142:34 pmRNSExercise of options
4th Nov 20147:00 amRNSGrant of Options
8th Oct 20147:00 amRNSExercise of options
25th Sep 20147:00 amRNSInterim results for the six months ended 30 June
17th Sep 20147:00 amRNSNotice of Interim Results
22nd Jul 20145:23 pmRNSHolding(s) in Company
22nd Jul 201411:11 amRNSHolding(s) in Company
22nd Jul 201411:08 amRNSHolding(s) in Company
21st Jul 20143:53 pmRNSHolding(s) in Company
16th Jul 20147:00 amRNSHolding(s) in Company
15th Jul 20143:13 pmRNSHolding(s) in Company
4th Jul 20142:44 pmRNSHolding(s) in Company
4th Jul 20147:00 amRNSPlacing
25th Jun 20147:00 amRNSHolding(s) in Company
12th Jun 20147:00 amRNSLicence deal with AstraZeneca
9th Jun 20141:00 pmRNSResult of AGM
16th May 20147:00 amRNSNotice of AGM
9th May 20142:57 pmRNSNotice of Report and Accounts
20th Mar 20147:00 amRNSPreliminary Results
11th Mar 20145:05 pmRNSHolding(s) in Company
6th Mar 201412:58 pmRNSHolding(s) in Company
5th Mar 20147:00 amRNSLicensing Update, Placing & Notice of results
14th Oct 20139:05 amRNSExercise of Options
12th Aug 20137:00 amRNSHalf Yearly Report
18th Jul 20137:00 amRNSPositive anti-inflammatory and anti-viral data
3rd Jul 20133:05 pmRNSHolding(s) in Company
10th Jun 20131:45 pmRNSResult of AGM
21st May 201311:10 amRNSHolding(s) in Company
9th May 201312:45 pmRNSNotice of AGM
9th Apr 20134:26 pmRNSPosting of Annual Report
12th Mar 20137:00 amRNSGrant of Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.